Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01470105 · ClinicalTrials.gov registry record
Improving a Bayesian Model's Survival Estimates in Patients Needing Surgery for Bone Metastases
A clinical trial of Bone Metastases, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- 230
- Enrollment target
- 2
- Study locations
NCT01470105: Active study of Bone Metastases, sponsored by Memorial Sloan Kettering Cancer Center.
NCT01470105 is a study of Bone Metastases that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 230 participants, above the 131-participant average among 10 other Bone Metastases trials with a reported enrollment target (76% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01470105, a study of Bone Metastases, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 230 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this study is to improve how we estimate survival of people with cancer that has spread to their bone. There have been previous attempts to estimate survival of people with cancer that spread to the bone, but they have not been accurate. This study will try to improve the way we estimate survival in people with cancer that has spread to their bone by looking to see if a physician assessment and a patient assessment of the health status can be blended to give a better estimate of survival than patients or doctors alone.
Primary Outcome
Whether the addition of serum inflammatory cytokines improves the robustness of an existing, validated Bayesian Belief network trained to estimate survival in human patients with operative skeletal metastases.
Conditions Studied
Interventions
- OTHER blood sampling, the SF-36 questionnaire
Study Locations (2)
New York
- Memorial Sloan Kettering Cancer Center - New York
- Montefiore Medical Center - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 230 participants |
| Start Date | 2011-11 |
| Est. Completion | 2026-11 |
What the registry record for NCT01470105 still lists
NCT01470105 is an observational study that tracks outcomes without assigning an intervention. The registered 230 participants enrollment target is mid-sized for trials with a published cap, above the 131-participant average among 10 other Bone Metastases trials with a reported enrollment target (76% higher).
The record links to 1 condition, with Bone Metastases appearing as the primary indexed condition, and to 1 intervention - of which blood sampling, the SF-36 questionnaire is the first listed.
NCT01470105 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT01470105 about?
NCT01470105 is a clinical study titled "Improving a Bayesian Model's Survival Estimates in Patients Needing Surgery for Bone Metastases". The goal of this study is to improve how we estimate survival of people with cancer that has spread to their bone. There have been previous attempts to estimate survival of people with cancer that spread to the bone, but they have not been accurate. This study will try to improve the way we estimate...
What is the current status of trial NCT01470105?
This trial is currently active not recruiting. The enrollment target is 230 participants. The study started on 2011-11. Estimated completion is 2026-11.
What conditions does trial NCT01470105 study?
This clinical trial studies the following conditions: Bone Metastases.
What interventions are being tested in trial NCT01470105?
The interventions under investigation include: blood sampling, the SF-36 questionnaire (OTHER).
Who is sponsoring clinical trial NCT01470105?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01470105 being conducted?
This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bone Metastases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01470105's enrollment target sits among peer trials
230 3rd of 10 higher than 8 of 10 other Bone Metastases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Bone Metastases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Abductor Reattachment Methods in Proximal Femur Replacements: What is the Best Method?
RECRUITING
-
Registry for Bone Metastases
RECRUITING
-
Simulation-Free, Single-Fraction Palliative Radiation Therapy for Treatment of Bone Metastases
RECRUITING · NA
-
Post-Op Pain Control for Prophylactic Intramedullary Nailing.
RECRUITING · Phase 3
-
A Phase III Randomized Trial Comparing Stereotactic Body Radiation Therapy (SBRT) vs Conventional Palliative Radiation Therapy for Painful Bone Metastases
RECRUITING · Phase 3
-
Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02710253 · 230 participants · Phase 2
Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy
- NCT02777879 · 230 participants
Lung Microbiome and Inflammation in Early COPD
- NCT03824483 · 230 participants · Phase 2
Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL)
- NCT03833622 · 230 participants · NA
Shared Decision Making to Improve Goals of Care in the ED
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia